The purpose of this study is to collect data on the use of commercially approved Boston Scientific drug-eluting devices used to treat peripheral vascular disease (PAD) to understand how these devices are being used in a routine hospital setting. We hope to potentially improve patient outcomes in the future as well as to understand how patient outcomes compare across diverse patient populations. The study data will also be used to continue monitoring the safety of these devices.

All visits are per standard of care and there are no separate study visits required.